
Gail F. LevineGail F.Levine
Partner, Antitrust
Gail Levine is a partner in Paul Hastings' Antitrust & Competition practice and is based in the firm’s Washington, D.C. office. A trusted adviser in business-critical mergers or acquisitions with antitrust issues, Gail represents clients such as Fortune 500 companies and private equity firms, handling their merger control matters, representing them in investigations and counseling them on antitrust risk. She also advises small and growing tech start-ups on a wide variety of issues as they scale, as well as high-tech companies in Federal Trade Commission (FTC) investigations into data privacy and security issues.
Supervised FTC challenge to a next-generation gene-sequencing firm’s plan to acquire an alleged nascent competitor (Illumina/PacBio).
Oversaw FTC’s action against a pharmaceutical firm and its corporate leadership for allegedly using anticompetitive tactics to shield its drug from price competition (FTC v. Vyera).
- Leading Global Antitrust & Competition Lawyers
Lawdragon 500 (2026)
- FTC Janet Steiger Award for outstanding contributions to Chairman’s 21st Century Hearings Team
“Deal Lawyers: New State Notification Requirements for Mergers and Acquisitions,” Deal Lawyers, Author
OCTOBER 16, 2025
“FTC Imposes Significant Gun-Jumping Penalty for Unlawful Pre-Merger Coordination Among Crude Oil Producers,” Compliance & Enforcement, Author
FEBRUARY 4, 2025
“FTCs Proposed HSR Changes Will Complicate Merger Filings,” Law360, Author
AUGUST 9, 2023
Vice Chair
Women.Connected, American Bar Association, Section of Antitrust Law (2020-25)
Member
Council, American Bar Association (2013-16)
- "Merger control & AI partnerships: what comes next?" GCR Live: AI in Transforming Markets, SpeakerMARCH 24, 2026
- “Non-Competes Across Antitrust, Labor, and Trade Secret Law: Where Do We Stand?” American Bar Association, SpeakerJANUARY 14, 2026